内分泌・代謝系 — 2020+ トピック

参考文献

1. 1.Jastreboff AM et al. Tirzepatide for Obesity (SURMOUNT-1). NEJM. 2022(2022)DOI
2. 2.Jastreboff AM et al. Retatrutide for Obesity (triple agonist). NEJM. 2023(2023)DOI
3. 3.Wharton S et al. Daily Oral GLP-1RA Orforglipron for Weight Loss. NEJM. 2023(2023)DOI
4. 4.Herold KC et al. Teplizumab for Delay of T1D Onset. NEJM. 2019 (PROTECT 2024 follow-up)(2019)DOI
5. 5.Fleseriu M et al. Osilodrostat in Cushing's Disease (LINC 3). Lancet Diabetes Endocrinol. 2020(2020)DOI
6. 6.Lingvay I et al. Once-weekly insulin icodec vs daily basal insulin. NEJM. 2023(2023)DOI
7. 7.Brown SA et al. Six-Month Trial of Closed-Loop System in T1D Adults and Children. NEJM. 2019(2019)DOI